Follow the 이연제약 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 이연제약 has logged 37 reports. Market capitalisation: €179.7bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 정순옥. The full history is accessible without an account.
37
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,875 of 29,057 companies
22.9
score / 100
Value
21
Quality
25
FCF yld-3.6%
Earn yld-16%
EV/EBITDA19.4x
ROE6.8%
Gross mgn26%
Net mgn-20%
Debt/EBITDA10.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
이연제약 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo y la fabricación de medicamentos innovadores.